1. Home
  2. MNKD vs ENVA Comparison

MNKD vs ENVA Comparison

Compare MNKD & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • ENVA
  • Stock Information
  • Founded
  • MNKD 1991
  • ENVA 2011
  • Country
  • MNKD United States
  • ENVA United States
  • Employees
  • MNKD N/A
  • ENVA N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • MNKD Health Care
  • ENVA Finance
  • Exchange
  • MNKD Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • MNKD 1.8B
  • ENVA 2.2B
  • IPO Year
  • MNKD 2004
  • ENVA N/A
  • Fundamental
  • Price
  • MNKD $6.80
  • ENVA $100.29
  • Analyst Decision
  • MNKD Strong Buy
  • ENVA Buy
  • Analyst Count
  • MNKD 5
  • ENVA 7
  • Target Price
  • MNKD $8.40
  • ENVA $88.00
  • AVG Volume (30 Days)
  • MNKD 2.9M
  • ENVA 261.8K
  • Earning Date
  • MNKD 11-07-2024
  • ENVA 10-22-2024
  • Dividend Yield
  • MNKD N/A
  • ENVA N/A
  • EPS Growth
  • MNKD N/A
  • ENVA 5.61
  • EPS
  • MNKD 0.08
  • ENVA 6.23
  • Revenue
  • MNKD $267,200,000.00
  • ENVA $1,170,788,000.00
  • Revenue This Year
  • MNKD $46.83
  • ENVA N/A
  • Revenue Next Year
  • MNKD $14.40
  • ENVA $17.77
  • P/E Ratio
  • MNKD $85.77
  • ENVA $16.13
  • Revenue Growth
  • MNKD 51.35
  • ENVA 14.80
  • 52 Week Low
  • MNKD $3.17
  • ENVA $39.59
  • 52 Week High
  • MNKD $7.63
  • ENVA $106.51
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 47.15
  • ENVA 67.65
  • Support Level
  • MNKD $6.61
  • ENVA $100.65
  • Resistance Level
  • MNKD $7.44
  • ENVA $106.51
  • Average True Range (ATR)
  • MNKD 0.35
  • ENVA 2.58
  • MACD
  • MNKD -0.05
  • ENVA 0.81
  • Stochastic Oscillator
  • MNKD 18.63
  • ENVA 74.19

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and the United Kingdom. Consumers apply for credit online, receive a decision almost immediately, and can receive funds within one day. Enova acts as either the lender or a third-party facilitator between borrowers and other lenders. The company earns revenue from interest income, finance charges, and other fees, including fees on the transactions between borrowers and third-party lenders. The majority of revenue comes from the United States. The company realizes similar amounts of revenue from each of its three different products: short-term loans, lines of credit, and installment loans.

Share on Social Networks: